New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

Today's Free Fly Stories
All of the free stories from today.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | all day >>
08:07 EDTGPOR, RICE, MWEGulfport Energy, Rice Energy in LOI for gas gathering pipelines
Subscribe for More Information
08:06 EDTTRKSpeedway Motorsports sees FY14 EPS 90c-$1.10, one estimate 92c
Subscribe for More Information
08:06 EDTRDYDr. Reddy's Labs reports Q1 EPS 54c vs. 35c last year
Reports Q1 revenue $586M vs. $474M last year.
08:06 EDTOREXOrexigen receives Day 180 List of Outstanding Issues from EMA
Subscribe for More Information
08:06 EDTAUOAU Optronics upgraded to Buy from Sell at Citigroup
Subscribe for More Information
08:06 EDTTRKSpeedway Motorsports reports Q2 adjusted EPS 66c, two estimates 67c
Reports Q2 revenue $175.9M, one estimate $173.92M.
08:06 EDTJACKJack in the Box shares should reach mid to high $60s, says Oppenheimer
Subscribe for More Information
08:05 EDTBOKFBOK Financial reports Q2 EPS $1.10, consensus $1.04
Subscribe for More Information
08:05 EDTGPORGulfport Energy reports Q2 production 26,725 BOEPD
Gulfport produced oil and natural gas sales volumes of 2,431,955 barrels of oil equivalent, or 26,725 barrels of oil equivalent per day, in line with the company's previously estimated guidance of approximately 27,100 BOEPD. For Q2, net production was 709,484 barrels of oil, 8,972,137 thousand cubic feet of natural gas and 9,538,843 gallons of natural gas liquids. Before the impact of derivatives, realized prices for Q2 were $99.40 per barrel of oil, $4.43 per MCF of natural gas and $1.14 per gallon of NGL, for a total equivalent of $49.81 per BOE. Gulfport's Q2 natural gas realized price before the impact of derivatives of $4.43 per Mcf represents a price realization of approximately 95% of the NYMEX settlement prices for the second quarter.
08:04 EDTEXC, TEGExelon acquires Integrys Energy unit for $60M
Subscribe for More Information
08:04 EDTARNAArena Pharmaceuticals and Eisai announce results of Lorcaserin Phase 2 trial
Arena Pharmaceuticals and Eisai announced that an article based on post-hoc analyses from the three pivotal Phase 3 trials of lorcaserin was recently published in the official peer reviewed journal of The Obesity Society. The objective of these analyses was to identify whether there is an early treatment milestone that can predict greater than or equal to 5% weight loss at one year in patients treated with lorcaserin. Belviq is a serotonin 2C receptor agonist approved in the U.S. as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in obese or overweight adults with at least one weight-related medical condition, such as high blood pressure, high cholesterol, or type 2 diabetes.
08:03 EDTWINWindstream upgraded to Buy from Neutral at DA Davidson
Subscribe for More Information
08:03 EDTRYAMRayonier Advanced Materials reports Q2 EPS 11c, consensus 84c
Subscribe for More Information
08:03 EDTPSXPhillips 66 reports Q2 EPS $1.51, consensus $1.70
Q2 earnings related to the company’s equity investment in DCP Midstream were $33M compared with $83M in Q1. The decrease reflects lower gains recorded by Phillips 66 on unit issuances of DCP Midstream Partners. Additionally, earnings were impacted by increased maintenance activity and lower NGL prices, partially offset by improved volumes. Midstream earnings were $108M in Q2, compared with earnings of $188M in Q1.
08:03 EDTCASHMeta Financial reports Q3 EPS 68c, consensus 77c
Subscribe for More Information
08:02 EDTLVLTLevel 3 downgraded to Neutral from Buy at DA Davidson
DA Davidson downgraded Level 3 to Neutral citing valuation. Price target remains $50.
08:01 EDTFNFV, FNFFidelity National Financial Ventures upgraded to Overweight from Equal Weight at Stephens
Subscribe for More Information
08:01 EDTLINTALiberty Interactive says still plans to create QVC Group tracking stock
Subscribe for More Information
08:01 EDTSEICSEI Investments upgraded at Oppenheimer
As noted earlier, Oppenheimer upgraded SEI Investments to Outperform from Perform. As reasons for the upgrade, the firm cited what it sees as the company's strong Q2 results, increased profitability as PB&T margins ramp, and attractive valuation. Target $42.
08:01 EDTPFE, BAXPfizer enters into agreement to acquire Baxter's portfolio of marketed vaccines
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | all day >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use